Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Maarten van der Heijden"'
Autor:
Denise Thomson, Miranda Cumpston, Netzahualpilli Delgado-Figueroa, Kristie L Ebi, Neal Haddaway, Maarten van der Heijden, Patricia C Heyn, Christian Lueme Lokotola, Joerg J Meerpohl, Maria-Inti Metzendorf, Eva Rawlings Parker, Revati Phalkey, David Tovey, Erik von Elm, Richard J Webster, Susan L Wieland, Taryn Young
Publikováno v:
Cochrane Database Syst Rev
Autor:
Ingrid Smith, Dzintars Gotham, Sarah Paulin, Peter Beyer, Maarten van der Heijden, Lorenzo Moja
Publikováno v:
Health policy (Amsterdam, Netherlands). 125(3)
Introduction The pipeline of new antibacterials remains limited. Reasons include low research investments, limited commercial prospects, and scientific challenges. To complement existing initiatives such as research grants, governments are exploring
Autor:
Peter J. F. Lucas, Jan H. Vercoulen, Erik Bischoff, Yvonne F. Heijdra, Tjard Schermer, Pim Assendelft, Maarten van der Heijden, Lonneke M. Boer, Reinier Akkermans
Publikováno v:
M-health/e-health.
Background: COPD exacerbations are often poorly recognized or self-managed, leading to increased disease burden and healthcare utilisation. Objective: To examine the effects of a smart mHealth tool that detects early exacerbation onset and directly p
Autor:
Lonneke M. Boer, Jan H. Vercoulen, Reinier Akkermans, Maarten van der Heijden, Erik Bischoff, Yvonne F. Heijdra, Willem J. J. Assendelft, Peter J. F. Lucas, Tjard Schermer
Publikováno v:
JMIR mHealth and uHealth, 7(10):e14408. JMIR
JMIR mHealth and uHealth, 7, 10
JMIR mHealth and uHealth, Vol 7, Iss 10, p e14408 (2019)
JMIR mHealth and uHealth, 7
JMIR mHealth and uHealth
JMIR mHealth and uHealth, 7, 10
JMIR mHealth and uHealth, Vol 7, Iss 10, p e14408 (2019)
JMIR mHealth and uHealth, 7
JMIR mHealth and uHealth
Background Many patients with chronic obstructive pulmonary disease (COPD) suffer from exacerbations, a worsening of their respiratory symptoms that warrants medical treatment. Exacerbations are often poorly recognized or managed by patients, leading
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::571cb21703e153c3e2ec9790c01ff5a4
https://research.utwente.nl/en/publications/8332e231-057e-4f84-9acc-e0a469f159fe
https://research.utwente.nl/en/publications/8332e231-057e-4f84-9acc-e0a469f159fe
Autor:
Willem J. J. Assendelft, Tjard Schermer, Erik Bischoff, Peter J. F. Lucas, Jan H. Vercoulen, Maarten van der Heijden, Nathalie Me van Kuijk, Lonneke M. Boer
Publikováno v:
International journal of COPD, 13, 3255-3267
International Journal of Chronic Obstructive Pulmonary Disease
International journal of COPD, 13, pp. 3255-3267
International Journal of Chronic Obstructive Pulmonary Disease
International journal of COPD, 13, pp. 3255-3267
Lonneke M Boer,1 Maarten van der Heijden,2 Nathalie ME van Kuijk,1 Peter JF Lucas,2 Jan H Vercoulen,3,4 Willem JJ Assendelft,1 Erik W Bischoff,1 Tjard R Schermer1,5 1Department of Primary and Community Care, Radboud university medical center, Radboud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dee56c2c4b7e2d9a18a878c36232fa1a
http://hdl.handle.net/2066/197198
http://hdl.handle.net/2066/197198
Publikováno v:
Computer, 2, 48, 32-39
Computer, 48, 2, pp. 32-39
Computer, 48, 32-39
Computer, 48, 2, pp. 32-39
Computer, 48, 32-39
Cost-effective mobile healthcare must consider not only technological performance but also the division of responsibilities between the patient and care provider, the context of the patient's condition, and ways to implement patient decision support
Autor:
Nathalie Me van Kuijk, Jan H. Vercoulen, Lonneke M. Boer, Tjard Schermer, Peter J. F. Lucas, Erik Bischoff, Maarten van der Heijden
Background: Early recognition and prompt treatment may reduce exacerbations and prevent complications in patients with COPD. However, many patients find it difficult to follow the instructions of written exacerbation action plans. To support patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cef380b23e8804cdcab3cb8cc7c5bf03
http://hdl.handle.net/1887/3202537
http://hdl.handle.net/1887/3202537
Publikováno v:
International Journal of Approximate Reasoning, 80, 460-474. Elsevier Science Inc.
Liu, M, Hommersom, A, van der Heijden, M & Lucas, P J F 2017, ' Hybrid time Bayesian networks ', International Journal of Approximate Reasoning, vol. 80, pp. 460-474 . https://doi.org/10.1016/j.ijar.2016.02.009
International Journal of Approximate Reasoning, 80, 460-474
International Journal of Approximate Reasoning, 80, pp. 460-474
Liu, M, Hommersom, A, van der Heijden, M & Lucas, P J F 2017, ' Hybrid time Bayesian networks ', International Journal of Approximate Reasoning, vol. 80, pp. 460-474 . https://doi.org/10.1016/j.ijar.2016.02.009
International Journal of Approximate Reasoning, 80, 460-474
International Journal of Approximate Reasoning, 80, pp. 460-474
Capturing heterogeneous dynamic systems in a probabilistic model is a challenging problem. A single time granularity, such as employed by dynamic Bayesian networks, provides insufficient flexibility to capture the dynamics of many real-world processe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ec627e44d16934454c4b672f8c61fa
http://hdl.handle.net/1887/3199642
http://hdl.handle.net/1887/3199642
Autor:
Suzan Verberne, Max Hinne, Wessel Kraaij, Eduard Hoenkamp, Maya Sappelli, Maarten van der Heijden, Saskia Koldijk
Publikováno v:
Journal of the American Society for Information Science and Technology. 64:2224-2237
In most intent recognition studies, annotations of query intent are created post hoc by external assessors who are not the searchers themselves. It is important for the field to get a better understanding of the quality of this process as an approxim
Publikováno v:
Journal of Biomedical Informatics, 46, 3, pp. 458-69
Journal of Biomedical Informatics, 46, 458-69
Journal of Biomedical Informatics, 46, 458-69
Item does not contain fulltext INTRODUCTION: Managing chronic disease through automated systems has the potential to both benefit the patient and reduce health-care costs. We have developed and evaluated a disease management system for patients with